Rate My Professor Trecia Wouldes

Wouldes' research centers on the developmental and behavioral impacts of prenatal exposure to substances including methamphetamine, methadone, opioids, and polysubstances, as well as neurocognitive outcomes in children born at risk of neonatal hypoglycemia or very preterm. She leads the New Zealand site of the Infant Development, Environment, and Lifestyle (IDEAL) Study, a multisite longitudinal project assessing methamphetamine-exposed infants' development in collaboration with US institutions. Additional contributions include follow-up analyses of the Metformin in Gestational Diabetes (MiG) trial offspring study and investigations into resilience factors in preterm infants and migrant youth. Her publications encompass over 100 works, with notable titles such as 'Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant' (2023, Frontiers in Pediatrics), 'Fostering Resilience to Very Preterm Birth Through the Caregiving Environment' (2022, JAMA Network Open), 'Prenatal methamphetamine—impact on the mother and child—a review' (2021, Addiction), 'Developmental and behavioral consequences of prenatal methamphetamine exposure' (2015, Current Epidemiology Reports), and 'Prenatal methamphetamine exposure and child behavioural outcomes at 5 years' (2014, Journal of Developmental & Behavioral Pediatrics). Wouldes' scholarship has garnered over 5,000 citations, influencing perinatal mental health and addiction research.